Related Experiment Videos

A human embryo fibroblast-derived peptide suppresses the zymosan-induced biochemical activation in human

Y Okai1

  • 1Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Yamaguchi, Japan.

Immunology Letters
|January 15, 1989
PubMed

Insights

A fibroblast-derived peptide inhibits human polymorphonuclear leukocytes (PMNs) functional activation, suppressing chemiluminescence and superoxide anion generation without causing cytotoxicity. This peptide impacts immune cell responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • A low-molecular-weight peptide from human embryo fibroblasts (YH-1 strain) was previously identified.
  • This peptide demonstrated inhibitory effects on B and T lymphocyte proliferation and function.

Purpose of the Study:

  • To investigate the effect of the fibroblast-derived peptide on the functional activation of human polymorphonuclear leukocytes (PMNs).
  • To determine if the peptide exhibits cytotoxic effects on PMNs.

Main Methods:

  • Human PMNs were stimulated with opsonized zymosan.
  • Chemiluminescence, superoxide anion generation, and RNA synthesis were measured.
  • Cytotoxicity was assessed using a cytoplasmic enzyme-releasing assay.

Main Results:

  • The peptide significantly suppressed opsonized zymosan-induced chemiluminescence and superoxide anion generation in PMNs.
  • Concomitant suppression of RNA synthesis was observed.
  • No significant cytotoxic effects on PMNs were detected.

Conclusions:

  • The fibroblast-derived peptide possesses suppressive activity on the functional activation of human PMNs.
  • This finding suggests a role for fibroblast-derived peptides in modulating innate immune cell responses.
  • The immunological significance of this peptide's effect on PMN function warrants further investigation.

Related Concept Videos